Ionis Pharmaceuticals, Inc. Peer Comparison
Metric | Value | Ranking | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $4.9 Billion | 10/18 | SGEN $43.2B |
ALNY $33.2B |
INCY $13.6B |
BMRN $12.4B |
SRPT $10.3B |
EXEL $9.8B |
HALO $7.4B |
MDGL $7.4B |
RETA $6.6B |
IONS $4.9B |
KRYS $4.4B |
PTCT $4.0B |
APLS $3.4B |
VKTX $3.4B |
ARWR $2.5B |
IOVA $1.7B |
ICPT $794.7M |
TERN $344.9M |
Gross Margin | 39% | 14/18 | ICPT 100% |
ALNY 99% |
MDGL 97% |
EXEL 96% |
RETA 96% |
INCY 92% |
PTCT 92% |
KRYS 90% |
HALO 83% |
APLS 81% |
SRPT 80% |
SGEN 75% |
BMRN 74% |
IONS 39% |
IOVA 32% |
VKTX 0% |
ARWR 0% |
TERN 0% |
Profit Margin | -100% | 16/18 | RETA 100% |
HALO 47% |
KRYS 32% |
EXEL 25% |
BMRN 14% |
INCY 9% |
SRPT 7% |
VKTX 0% |
ARWR 0% |
TERN 0% |
ICPT -3% |
ALNY -27% |
SGEN -33% |
APLS -33% |
PTCT -79% |
IONS -100% |
IOVA -100% |
MDGL -100% |
EBITDA margin | -196% | 17/18 | HALO 56% |
EXEL 30% |
KRYS 27% |
BMRN 16% |
INCY 16% |
SRPT 5% |
ICPT -3% |
ALNY -18% |
SGEN -34% |
APLS -38% |
PTCT -40% |
VKTX -100% |
ARWR -100% |
TERN -100% |
IOVA -152% |
MDGL -166% |
IONS -196% |
RETA -356% |
Quarterly Revenue | $75.7 Million | 12/18 | BMRN $733.9B |
INCY $1.1B |
SGEN $648.7M |
EXEL $566.8M |
SRPT $467.2M |
ALNY $420.1M |
HALO $290.1M |
APLS $176.6M |
PTCT $135.4M |
ICPT $88.8M |
KRYS $83.8M |
IONS $75.7M |
MDGL $62.2M |
IOVA $58.6M |
RETA $22.7M |
VKTX $0 |
ARWR $0 |
TERN $0 |
Quarterly Earnings | -$140.5 Million | 16/18 | BMRN $106.1B |
RETA $193.0M |
EXEL $139.9M |
HALO $137.0M |
INCY $106.5M |
SRPT $33.6M |
KRYS $27.2M |
ICPT -$2.8M |
TERN -$21.9M |
VKTX -$24.9M |
APLS -$57.4M |
IOVA -$83.5M |
PTCT -$106.7M |
MDGL -$107.0M |
ALNY -$111.6M |
IONS -$140.5M |
ARWR -$170.5M |
SGEN -$215.8M |
Quarterly Free Cash Flow | -$108.8 Million | 17/18 | BMRN $321.2B |
INCY $293.2M |
EXEL $226.3M |
HALO $113.9M |
KRYS $57.8M |
ALNY $39.5M |
APLS $34.1M |
ICPT $3.9M |
TERN -$16.5M |
VKTX -$22.0M |
PTCT -$22.8M |
IOVA -$61.3M |
MDGL -$62.8M |
RETA -$70.2M |
SGEN -$79.8M |
SRPT -$98.0M |
IONS -$108.8M |
ARWR -$161.5M |
Trailing 4 Quarters Revenue | $744.7 Million | 9/18 | BMRN $1.4T |
INCY $4.1B |
SGEN $2.3B |
EXEL $2.1B |
ALNY $2.0B |
SRPT $1.6B |
HALO $947.4M |
PTCT $839.3M |
IONS $744.7M |
APLS $675.9M |
ICPT $317.7M |
KRYS $241.5M |
IOVA $90.9M |
MDGL $76.8M |
RETA $24.4M |
ARWR $3.6M |
VKTX $0 |
TERN $0 |
Trailing 4 Quarters Earnings | -$358.5 Million | 13/18 | BMRN $733.9B |
INCY $1.1B |
SGEN $648.7M |
EXEL $566.8M |
SRPT $467.2M |
ALNY $420.1M |
HALO $290.1M |
APLS $176.6M |
PTCT $135.4M |
ICPT $88.8M |
KRYS $83.8M |
IONS $75.7M |
MDGL $62.2M |
IOVA $58.6M |
RETA $22.7M |
VKTX -$0 |
ARWR -$0 |
TERN -$0 |
Quarterly Earnings Growth | 4% | 11/18 | BMRN 262617% |
RETA 362% |
SRPT 182% |
KRYS 182% |
HALO 67% |
EXEL 64% |
APLS 59% |
IOVA 27% |
TERN 26% |
PTCT 20% |
IONS 4% |
MDGL -8% |
VKTX -11% |
SGEN -13% |
INCY -38% |
ARWR -55% |
ICPT -101% |
ALNY -176% |
Annual Earnings Growth | 11% | 9/18 | EXEL 488% |
SRPT 208% |
KRYS 133% |
RETA 72% |
ALNY 51% |
APLS 51% |
PTCT 38% |
HALO 28% |
IONS 11% |
IOVA 5% |
TERN -6% |
VKTX -24% |
BMRN -25% |
SGEN -26% |
ARWR -43% |
MDGL -46% |
INCY -96% |
ICPT -124% |
Quarterly Revenue Growth | -47% | 17/18 | BMRN 126140% |
IOVA 12385% |
RETA 2885% |
APLS 78% |
SRPT 41% |
HALO 34% |
SGEN 27% |
INCY 24% |
EXEL 18% |
ICPT 14% |
VKTX 0% |
MDGL 0% |
KRYS 0% |
TERN 0% |
PTCT -31% |
ALNY -44% |
IONS -47% |
ARWR -100% |
Annual Revenue Growth | 5% | 11/18 | IOVA 7580% |
RETA 596% |
APLS 76% |
SRPT 47% |
ALNY 18% |
SGEN 15% |
EXEL 11% |
HALO 8% |
INCY 8% |
ICPT 8% |
IONS 5% |
VKTX 0% |
MDGL 0% |
PTCT 0% |
KRYS 0% |
TERN 0% |
BMRN -23% |
ARWR -94% |
Cash On Hand | $334.6 Million | 8/18 | BMRN $675.4B |
INCY $1.3B |
ALNY $1.1B |
PTCT $526.0M |
SGEN $428.6M |
APLS $396.9M |
KRYS $374.0M |
IONS $334.6M |
TERN $270.1M |
MDGL $232.7M |
EXEL $217.4M |
SRPT $197.9M |
IOVA $164.2M |
HALO $154.3M |
ICPT $102.7M |
ARWR $102.7M |
VKTX $50.3M |
RETA $48.8M |
Short Term Debt | $44.0 Million | 2/18 | SRPT $91.6M |
IONS $44.0M |
ALNY $42.1M |
PTCT $16.8M |
BMRN $15.6M |
IOVA $11.6M |
APLS $6.8M |
ARWR $6.3M |
INCY $3.9M |
RETA $2.5M |
KRYS $1.3M |
MDGL $878,000 |
VKTX $480,000 |
TERN $272,000 |
EXEL -$0 |
HALO -$0 |
SGEN -$0 |
ICPT -$0 |
Long Term Debt | $1.4 Billion | 3/18 | BMRN $594.6B |
HALO $1.5B |
IONS $1.4B |
SRPT $1.3B |
ALNY $1.3B |
ARWR $504.2M |
PTCT $383.5M |
ICPT $223.9M |
EXEL $190.8M |
RETA $163.5M |
MDGL $118.3M |
SGEN $113.5M |
APLS $104.7M |
IOVA $66.4M |
INCY $28.2M |
TERN $1.0M |
VKTX $755,000 |
KRYS $0 |
PE | -1.00 | 7/18 | INCY 419.55 |
SRPT 84.63 |
KRYS 84.15 |
HALO 18.90 |
EXEL 18.79 |
BMRN 0.10 |
IONS -1.00 |
ALNY -1.00 |
VKTX -1.00 |
RETA -1.00 |
SGEN -1.00 |
ARWR -1.00 |
ICPT -1.00 |
IOVA -1.00 |
MDGL -1.00 |
PTCT -1.00 |
APLS -1.00 |
TERN -1.00 |
PS | 6.58 | 9/18 | ARWR 708.44 |
RETA 269.17 |
MDGL 95.75 |
SGEN 18.76 |
IOVA 18.68 |
KRYS 18.25 |
ALNY 16.48 |
HALO 7.83 |
IONS 6.58 |
SRPT 6.29 |
APLS 5.04 |
PTCT 4.76 |
EXEL 4.65 |
INCY 3.34 |
ICPT 2.50 |
BMRN 0.01 |
VKTX -1.00 |
TERN -1.00 |
PB | 7.40 | 10/18 | ALNY 1026.12 |
RETA 75.22 |
SGEN 16.92 |
HALO 16.38 |
APLS 14.37 |
ARWR 13.17 |
ICPT 11.06 |
MDGL 9.46 |
SRPT 8.44 |
IONS 7.40 |
KRYS 4.98 |
EXEL 4.36 |
INCY 4.30 |
VKTX 3.73 |
IOVA 2.19 |
TERN 0.95 |
BMRN 0.00 |
PTCT 0.00 |
PC | 14.65 | 10/18 | RETA 134.44 |
SGEN 100.70 |
VKTX 67.46 |
SRPT 52.12 |
HALO 48.06 |
EXEL 45.06 |
MDGL 31.61 |
ALNY 30.18 |
ARWR 24.50 |
IONS 14.65 |
KRYS 11.79 |
INCY 10.45 |
IOVA 10.34 |
APLS 8.59 |
ICPT 7.74 |
PTCT 7.60 |
TERN 1.28 |
BMRN 0.02 |
Liabilities to Equity | 3.65 | 6/18 | ALNY 128.97 |
ARWR 5.12 |
RETA 4.76 |
ICPT 4.47 |
HALO 3.68 |
IONS 3.65 |
APLS 2.80 |
SRPT 1.95 |
INCY 0.58 |
SGEN 0.42 |
MDGL 0.38 |
EXEL 0.31 |
IOVA 0.28 |
BMRN 0.27 |
KRYS 0.11 |
TERN 0.04 |
VKTX 0.03 |
PTCT 0.00 |
ROA | -0.12 | 9/18 | HALO 19% | EXEL 18% | KRYS 5% | SRPT 3% | BMRN 2% | INCY 1% | ALNY -8% | VKTX -11% | IONS -12% | ICPT -15% | RETA -16% | SGEN -21% | TERN -23% | PTCT -25% | APLS -28% | IOVA -41% | MDGL -48% | ARWR -53% |
ROE | -0.54 | 12/18 | HALO 87% |
PTCT 43% |
EXEL 23% |
SRPT 10% |
KRYS 6% |
BMRN 2% |
INCY 1% |
VKTX -11% |
TERN -24% |
SGEN -29% |
IOVA -53% |
IONS -54% |
MDGL -67% |
ICPT -82% |
RETA -94% |
APLS -105% |
ARWR -323% |
ALNY -1027% |
Current Ratio | 1.27 | 12/18 | VKTX 35.47 |
TERN 27.48 |
KRYS 10.18 |
BMRN 4.77 |
IOVA 4.55 |
EXEL 4.19 |
MDGL 3.62 |
SGEN 3.35 |
INCY 2.72 |
SRPT 1.51 |
APLS 1.36 |
IONS 1.27 |
HALO 1.27 |
ICPT 1.22 |
RETA 1.21 |
ARWR 1.20 |
ALNY 1.01 |
PTCT 0.64 |
Quick Ratio | 1.03 | 8/18 | INCY 419.55 |
SRPT 84.63 |
KRYS 84.15 |
HALO 18.90 |
EXEL 18.79 |
BMRN 0.10 |
IONS -1.00 |
ALNY -1.00 |
VKTX -1.00 |
RETA -1.00 |
SGEN -1.00 |
ARWR -1.00 |
ICPT -1.00 |
IOVA -1.00 |
MDGL -1.00 |
PTCT -1.00 |
APLS -1.00 |
TERN -1.00 |
Long Term Debt to Equity | 2.18 | 5/18 | ALNY} 38.93 |
HALO} 3.32 |
ICPT} 3.12 |
ARWR} 2.72 |
IONS} 2.18 |
RETA} 1.87 |
SRPT} 1.07 |
APLS} 0.44 |
MDGL} 0.15 |
BMRN} 0.11 |
EXEL} 0.09 |
IOVA} 0.09 |
SGEN} 0.04 |
INCY} 0.01 |
VKTX} 0.00 |
KRYS} 0.00 |
TERN} 0.00 |
PTCT} -0.36 |
Debt to Equity | 2.18 | 5/18 | ALNY 40.24 |
HALO 3.32 |
ICPT 3.12 |
ARWR 2.75 |
IONS 2.18 |
RETA 1.90 |
SRPT 1.14 |
APLS 0.47 |
BMRN 0.11 |
IOVA 0.10 |
EXEL 0.09 |
SGEN 0.04 |
INCY 0.01 |
VKTX 0.00 |
MDGL 0.00 |
KRYS 0.00 |
TERN 0.00 |
PTCT -0.38 |
Burn Rate | 1.60 | 11/18 | TERN 12.25 |
ICPT 8.75 |
ALNY 6.38 |
APLS 6.27 |
SRPT 4.76 |
PTCT 4.17 |
MDGL 2.08 |
VKTX 2.01 |
SGEN 1.95 |
IOVA 1.84 |
IONS 1.60 |
ARWR 0.53 |
RETA -0.26 |
EXEL -1.64 |
HALO -2.01 |
BMRN -8.21 |
INCY -12.50 |
KRYS -13.92 |
Cash to Cap | 0.07 | 9/18 | BMRN 54.65 |
TERN 0.78 |
ICPT 0.13 |
PTCT 0.13 |
APLS 0.12 |
INCY 0.10 |
IOVA 0.10 |
KRYS 0.08 |
IONS 0.07 |
ARWR 0.04 |
ALNY 0.03 |
MDGL 0.03 |
EXEL 0.02 |
HALO 0.02 |
SRPT 0.02 |
VKTX 0.01 |
RETA 0.01 |
SGEN 0.01 |
CCR | 0.77 | 8/18 | BMRN 3.03 |
INCY 2.75 |
KRYS 2.13 |
EXEL 1.62 |
ARWR 0.95 |
VKTX 0.88 |
HALO 0.83 |
IONS 0.77 |
TERN 0.75 |
IOVA 0.73 |
MDGL 0.59 |
SGEN 0.37 |
PTCT 0.21 |
ALNY -0.35 |
RETA -0.36 |
APLS -0.59 |
ICPT -1.38 |
SRPT -2.91 |
EV to EBITDA | -40.45 | 11/18 | SRPT} 518.61 |
KRYS} 179.85 |
INCY} 68.71 |
EXEL} 57.10 |
HALO} 53.71 |
BMRN} -0.60 |
VKTX} -1.00 |
TERN} -1.00 |
IOVA} -18.09 |
ARWR} -19.09 |
IONS} -40.45 |
APLS} -46.24 |
MDGL} -69.16 |
PTCT} -71.01 |
RETA} -82.50 |
SGEN} -191.83 |
ICPT} -331.82 |
ALNY} -434.32 |
EV to Revenue | 8.07 | 9/18 | ARWR 823.30 |
RETA 273.97 |
MDGL 92.73 |
SGEN 18.62 |
IOVA 17.74 |
KRYS 16.71 |
ALNY 16.58 |
HALO 9.25 |
IONS 8.07 |
SRPT 7.02 |
EXEL 4.64 |
APLS 4.62 |
PTCT 4.61 |
INCY 3.03 |
ICPT 2.88 |
BMRN -0.05 |
VKTX -1.00 |
TERN -1.00 |